Evidence map›Paper›PMID 39283536›Full record

ArticleAnnals of nuclear medicine2025

Next day sentinel node biopsy for melanoma after lymphoscintigraphy using

Amit Roshan, Terouz Pasha, Georgios Kounidas, Suzanne Murphy, Luigi Aloj, John Buscombe, Animesh Patel, Amer Durrani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amit RoshanDepartment of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. amit.roshan@cruk.cam.ac.uk.ORCID http://orcid.org/0000-0002-2034-2759
Terouz PashaDepartment of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID http://orcid.org/0000-0002-5339-8839
Georgios KounidasDepartment of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID http://orcid.org/0000-0002-1580-2917
Suzanne MurphyDepartment of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID http://orcid.org/0000-0001-5589-0774
Luigi AlojDepartment of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID http://orcid.org/0000-0002-7452-4961
John BuscombeDepartment of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Animesh PatelDepartment of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Amer DurraniDepartment of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID http://orcid.org/0000-0002-6105-258X

Funding

Cancer Research UK Cambridge Institute, University of Cambridge C64667/A27958
6 · The paper itself

Abstract

objectiveSentinel Lymph Node Biopsy (SLNB) is an important management tool for early-stage melanoma. Different radiopharmaceuticals are used internationally to localise the sentinel node using lymphoscintigraphy (LSG) before surgery. Recent reports have suggested that a delayed interval between LSG and SLNB using

methodsOutcome data were reviewed for patients undergoing SLNB, stratified by time interval between LSG and SLNB at a single UK academic centre. Kaplan-Meier survival analysis was used to assess overall survival (OS), melanoma-specific survival (MSS) and progression-free survival (PFS). Cox multivariable regression analysis identified independent risk factors.

results925 patients had LSG using the

conclusionsWe do not find a significant effect on long-term outcomes when SLNB is performed the day after LSG with

Indexed as

LymphoscintigraphyMelanomaSentinel Lymph Node BiopsyTechnetium Tc 99m Aggregated AlbuminAdultAgedFemaleHumansMaleMiddle AgedTime FactorsTreatment OutcomeTechnetium Tc 99m Aggregated Albumintechnetium Tc 99m nanocolloidMelanomaNanocolloidSentinel lymph nodeTiming

Identifiers

PMID39283536
PMCPMC11706919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.